St Jude Medical
STJ
STJ was delisted on the 4th of January, 2017.
534 hedge funds and large institutions have $15.4B invested in St Jude Medical in 2013 Q4 according to their latest regulatory filings, with 82 funds opening new positions, 178 increasing their positions, 204 reducing their positions, and 29 closing their positions.
183% more first-time investments, than exits
New positions opened: 82 | Existing positions closed: 29
14% more capital invested
Capital invested by funds: $13.5B → $15.4B (+$1.9B)
10% more funds holding
Funds holding: 486 → 534 (+48)
13% less repeat investments, than reductions
Existing positions increased: 178 | Existing positions reduced: 204
17% less funds holding in top 10
Funds holding in top 10: 12 → 10 (-2)
40% less call options, than puts
Call options by funds: $45.7M | Put options by funds: $76.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$143M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$127M |
| 3 |
FAM
Fred Alger Management
New York
|
+$90.2M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$86.1M |
| 5 |
CCI
Columbus Circle Investors
|
+$83.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$277M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$163M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$151M |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
-$106M |
| 5 |
Bank of New York Mellon
New York
|
-$83.5M |
STJ Hedge Fund Activity: Q4 2013 in Review
534 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in St Jude Medical (STJ) for Q4 2013, worth a combined $15.4B — up 14% from $13.5B a quarter earlier.
Buyers outnumbered sellers: 82 funds opened new STJ positions and 29 closed out — a net gain of 53 holders — while 178 added to existing stakes and 204 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $143M. The largest seller was Massachusetts Financial Services, cutting an estimated $277M.
- 534 institutional investors held St Jude Medical (STJ) as of Q4 2013, up from 486 in Q3 2013.
- Funds reported $15.4B of St Jude Medical stock for Q4 2013, up 14% quarter-over-quarter.
- 82 funds opened new St Jude Medical positions in Q4 2013 and 29 closed out, a net change of +53 holders.
- The largest St Jude Medical buyer in Q4 2013 was T. Rowe Price Associates, an estimated $143M added.
- The largest St Jude Medical seller in Q4 2013 was Massachusetts Financial Services, an estimated $277M sold.
Based on aggregated 13F filings for Q4 2013.